---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-079163"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:05:02.576743+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Treace Medical Q4 revenue $62.5M (-9% YoY); guides FY2026 revenue down 0-6%

## Summary
- Q4 revenue $62.5M, down 9% YoY; net loss $(9.4)M vs $(0.5)M in prior year.
- FY2025 revenue $212.7M, up 2% YoY; net loss $(59.0)M vs $(55.7)M; adj. EBITDA loss $(3.9)M.
- Guidance: FY2026 revenue $200-212M (decline 0-6%); adj. EBITDA loss $4-6M.
- Cash used fell 46% to $27.3M in FY2025; active surgeons +6% to 3,337.

## SEC filing metadata
- accession: 0001193125-26-079163
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/0001193125-26-079163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/tmci-20260227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-079163
- JSON: https://secwatch.observer/filing/0001193125-26-079163.json
- Plain text: https://secwatch.observer/filing/0001193125-26-079163.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.